From penetrating solid tumors to new success rates for de novo design, the next wave of antibody therapies aims to transform the clinic.
Polaryx believes the addition of Dr. Berger, Mr. Braun, and Dr. Ryan brings valuable expertise across scientific research, ...
Discover how scientists created a tasty, eco-friendly vegan protein using fungal mycelium grown on food waste—that beats soy ...
The Super Bowl-bound Patriots and Seahawks got their mojo back. But their home cities are on an economic losing streak.
Ascentage Pharma will be conducting a multicenter, open-label Phase I study designed to evaluate the safety, tolerability, ...
Explore GoodHaven Fund's 2025 results and portfolio strategy. See how we navigate market volatility for long-term growth by ...
With his controversial sporting endeavour backed by a Trump, the Enhanced Games founder has come a long way from sweeping ...
Now let’s move to some lighter political gossip to ease the mood a bit, one of which again emerged from the communications legend Nikos Karachalias, who said that in an interview he gives to ANT1, ...
Top venture capital firms are assessed by their investment strategies, sector focus, and how they help startups grow beyond ...
Mayer Brown has hired City real estate duo Mark Rajbenbach and Victoria Butcher from Taylor Wessing, ahead of the UK firm’s transatlantic merger with Winston & Strawn. Butcher joined Taylor Wessing as ...
On January 30, 2026, the U.S. District Court for the District of New Jersey entered a Joint Stipulation of Dismissal resolving the pertuzumab ...
The stock price has climbed in the triple digits over three years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results